PHR (Phreesia) Future 3-5Y Total Revenue Growth Rate : 12.23 (As of Jul. 12, 2025)

View and export this data going back to 2019. Start your Free Trial

What is Phreesia Future 3-5Y Total Revenue Growth Rate?

Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.

As of today, Phreesia's Future 3-5Y Total Revenue Growth Rate is 12.23.

Competitive Comparison of Phreesia's Future 3-5Y Total Revenue Growth Rate

For the Health Information Services subindustry, Phreesia's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phreesia's Future 3-5Y Total Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Phreesia's Future 3-5Y Total Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Phreesia (NYSE:PHR) Future 3-5Y Total Revenue Growth Rate Explanation

Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.

In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.

Phreesia Future 3-5Y Total Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Phreesia's Future 3-5Y Total Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Phreesia Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Phreesia Inc (NYSE:PHR) » Definitions » Future 3-5Y Total Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

19P:Germany

Address

1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803

Website

https://www.phreesia.com

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

Executives

David Linetsky	officer: SVP, Life Sciences	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Balaji Gandhi	officer: Chief Financial Officer	PHREESIA, INC., 1521 CONCORD PIKE, SUITE 301, PMB 221, WILMINGTON DE 19803
Allison C Hoffman	officer: General Counsel & Secretary	315 EAST 68TH STREET, NEW YORK NY 10065
Amy Beth Vanduyn	officer: SVP, Human Resources	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Chaim Indig	director, officer: Chief Executive Officer	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Evan Roberts	officer: Chief Operating Officer	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Michael Weintraub	director	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Lisa Egbuonu-davis	director	C/O OMEGA HEALTHCARE INVESTORS, INC., 303 INTERNATIONAL CIRCLE, SUITE 200, HUNT VALLEY MD 21030
Mark Douglas Smith	director	C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE NY 10577
Janet Gunzburg	officer: Principal Accounting Officer	BANKRATE, INC., 477 MADISON AVENUE, SUITE 430, NEW YORK NY 10022
Michael J. Davidoff	officer: See Remarks	C/O PHREESIA, INC., 432 PARK AVENUE S., 12TH FLOOR, NEW YORK NY 10016
Gillian Munson	director	C/O XO GROUP INC., 195 BROADWAY, 25TH FLOOR, NEW YORK NY 10007
Randy Rasmussen	officer: Chief Financial Officer	PHREESIA, INC., 434 FAYETTEVILLE ST., SUITE 1400, RALEIGH NC 27601
Ramin Sayar	director	305 MAIN STREET, REDWOOD CITY CA 94063
Edward L Cahill	10 percent owner	C/O HLM VENTURE PARTNERS, 800 SOUTH STREET, SUITE 200, WALTHAM MA 02453